) (31.1%) 1,767.6 2,388.2 620.6 35.1% Gross Profit/2 2,159.1 1,163.7 (995.5) (46.1%) 3,005.2 3,082.3 77.1 2.6% Net Profit 972.4 303.0 (669.3) (68.8%) 1,053.1 1,082.9 29.8 2.8% Normalized Total Revenue/3
) (31.1%) 1,767.6 2,388.2 620.6 35.1% Gross Profit/2 2,159.1 1,163.7 (995.5) (46.1%) 3,005.2 3,082.3 77.1 2.6% Net Profit 972.4 303.0 (669.3) (68.8%) 1,053.1 1,082.9 29.8 2.8% Normalized Total Revenue/3
) - (870.5) N.A.(
1Q18 compare to in 1Q17, the Company EBITDA slightly decreased from 11.5 percent to 10.1 percent. Net Profit At the end of 1Q18, the Company and its subsidiaries earn the net profit in the amount of THB
Earnings before interest and taxes (EBIT) 17.67 28.17 (10.50) (37.27) Financial costs 0.04 0.04 - - Income tax expenses 1.86 5.46 (3.60) (65.93) Net profit 15.77 22.68 (6.91) (30.46) Earnings before interest
doubtful accounts of Baht 50.55 million, and impairment on assets of Baht 5.61 million, the operations for year 2018 showed a loss of Baht 168.95 million. Compared to the same period of 2017, the profit was
Microsoft Word - MDA FY18 EN February 20, 2019 To President The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent
2019-11-14 - ชี้แจงเปลี่ยนแปลงมากกว่า 20% Q3-2562 - ENG November 14, 2019 Subject: The clarification of the quarter 3/2019’s profit changing more than 20% Attention: The President The Stock Exchange
on dissolution of Solvay Biochemicals (Taixing) Limited amounting to 89 MB from other comprehensive income to the profit of the year 2018. Summary of Performance For the year 2019, the Company and its
reasons the company’s net profit (net loss) or net income increased more than 20% from last year. Dear Sirs : Karmarts Public Company Limited would like to submit financial statement for the year ended